Solid Biosciences Inc.
SLDB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $61 | $139 | $211 | $80 |
| Short-Term Investments | $175 | $129 | $96 | $69 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $9 | $11 | $6 | $8 |
| Total Curr. Assets | $245 | $279 | $313 | $157 |
| Property Plant & Equip (Net) | $27 | $27 | $28 | $29 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $29 | $30 | $30 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $274 | $308 | $344 | $189 |
| Liabilities | – | – | – | – |
| Payables | $8 | $5 | $6 | $4 |
| Short-Term Debt | $2 | $3 | $3 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $26 | $22 | $19 | $23 |
| Total Curr. Liab. | $36 | $30 | $29 | $30 |
| LT Debt | $20 | $20 | $21 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $20 | $20 | $21 | $21 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $22 | $23 | $24 | $24 |
| Total Liabilities | $56 | $50 | $49 | $51 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$908 | -$862 | -$823 | -$783 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $1,126 | $1,120 | $1,117 | $921 |
| Total Equity | $218 | $258 | $294 | $137 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $274 | $308 | $344 | $189 |
| Net Debt | -$39 | -$116 | -$187 | -$56 |